BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37737900)

  • 21. The urinary microbiota composition and functionality of calcium oxalate stone formers.
    Xie J; Zhang XQ; Guo JN; Yuan Q; Xiao KF; Yuan YQ
    Front Cell Infect Microbiol; 2024; 14():1394955. PubMed ID: 38912208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of Clinical Microbiome Studies in Urolithiasis Reveal Age, Stone Composition, and Study Location as the Predominant Factors in Urolithiasis-Associated Microbiome Composition.
    Kachroo N; Lange D; Penniston KL; Stern J; Tasian G; Bajic P; Wolfe AJ; Suryavanshi M; Ticinesi A; Meschi T; Monga M; Miller AW
    mBio; 2021 Aug; 12(4):e0200721. PubMed ID: 34372696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.
    Mariotti ACH; Heidrich V; Inoue LT; Coser EM; Dos Santos EX; Dos Santos HDB; Rocha CBT; Asprino PF; Bettoni F; Bastos DA; Jardim DLF; Camargo AA; Arap MA
    Prostate; 2024 Feb; 84(3):285-291. PubMed ID: 37961000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Microbiome and Psychological Factors in Women with Overactive Bladder.
    Wu P; Chen Y; Zhao J; Zhang G; Chen J; Wang J; Zhang H
    Front Cell Infect Microbiol; 2017; 7():488. PubMed ID: 29230385
    [No Abstract]   [Full Text] [Related]  

  • 25. The controversial association of gut and urinary microbiota with kidney stone formation.
    Bostanghadiri N; Ziaeefar P; Sameni F; Mahmoudi M; Hashemi A; Darban-Sarokhalil D
    Microb Pathog; 2021 Dec; 161(Pt A):105257. PubMed ID: 34687841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying Two Novel Clusters in Calcium Oxalate Stones With Urinary Tract Infection Using 16S rDNA Sequencing.
    Shen C; Zhu Q; Dong F; Wang W; Fan B; Li K; Chen J; Hu S; He Z; Li X
    Front Cell Infect Microbiol; 2021; 11():723781. PubMed ID: 34869053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
    Höfner K; Burkart M; Jacob G; Jonas U
    World J Urol; 2010 Jun; 28(3):353-7. PubMed ID: 19997921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
    Peyronnet B; Brucker BM; Michel MC
    Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?
    Matsukawa Y; Majima T; Takai S; Funahashi Y; Kato M; Gotoh M
    Urol Int; 2019; 103(4):439-443. PubMed ID: 31554005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.
    Burnett AL; Walker DR; Feng Q; Johnston KM; Lozano-Ortega G; Nimke D; Hairston JC
    Neurourol Urodyn; 2020 Jun; 39(5):1378-1386. PubMed ID: 32383533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Analysis of the Effects of Executive Functions, Working Memory and Other Factors on Medication Adherence in Elderly Men with Benign Prostatic Hyperplasia and Overactive Bladder Symptoms.
    Kosilov K; Kuzina I; Kuznetsov V; Kosilova L; Ivanovskaya M; Kosilova E
    Curr Aging Sci; 2020; 13(1):72-80. PubMed ID: 31560296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.
    Lee SH; Kim DK; Kim JC; Lee KS; Lee JG; Park CH; Hong SJ; Kim CS; Park JK; Chung BH
    Yonsei Med J; 2010 May; 51(3):432-7. PubMed ID: 20376898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study.
    Yamanishi T; Asakura H; Seki N; Tokunaga S
    Urol Int; 2021; 105(9-10):817-825. PubMed ID: 33690238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary prostaglandins E2 correlates to overactive bladder symptoms in patients with benign prostatic hyperplasia].
    Zhang YJ; Bai Q
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):244-8. PubMed ID: 24738462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms.
    Park YH; Kim TH; Lee SW; Chung BH; Cho JS; Lee JY
    Low Urin Tract Symptoms; 2017 May; 9(2):75-81. PubMed ID: 28394492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats.
    Wang Y; Sun J; Xie S; Zhou Y; Wang T; Liu Z; Li C; Gao L; Pan T
    Front Cell Infect Microbiol; 2023; 13():1145196. PubMed ID: 37313343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Calcium Oxalate on Expression of Clusterin and Lower Urinary Tract Symptoms in Prostatitis and Benign Prostatic Hyperplasia Patients with Calculi.
    Sun C; Xie G; Huang F; Liu X
    Med Sci Monit; 2018 Dec; 24():9196-9203. PubMed ID: 30560838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vibegron, a novel β
    Maruyama I; Yamamoto S; Tsuchioka K; Yamazaki T
    Eur J Pharmacol; 2020 Jul; 878():173096. PubMed ID: 32259514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.